CXC chemokine receptor‐1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Hepatology

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.24028PMID 21254176PMCID PMC3058860
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CNS Leptin Action Modulates Immune Response and Survival in Sepsis

  2010cited by this paper
• The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis1

  2009cited by this paper
• Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice.

  2008cited by this paper
• Hepatocyte signaling through CXC chemokine receptor‐2 is detrimental to liver recovery after ischemia/reperfusion in mice

  2008cited by this paper
• The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro.

  2007cited by this paper
• Peroxisome proliferator‐activated receptor‐γ protects against hepatic ischemia/reperfusion injury in mice

  2007cited by this paper
• Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8*

  2007cited by this paper
• The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro.

  2007cited by this paper
• ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.

  2006cited by this paper
• A homolog of the human chemokine receptor CXCR1 is expressed in the mouse.

  2006cited by this paper
• Distinct and sequential upregulation of genes regulating cell growth and cell cycle progression during hepatic ischemia-reperfusion injury.

  2005cited by this paper
• Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1.

  2005cited by this paper
• Neutrophil Recruitment in the Reperfused-Injured Rat Liver was Effectively Attenuated by Repertaxin, a Novel Allosteric Noncompetitive Inhibitor of Cxcl8 Receptors: A Therapeutic Approach for the Treatment of Post-Ischemic Hepatic Syndromes

  2005cited by this paper
• Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

  2004cited by this paper
• Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.

  2003cited by this paper
• Disruption of Neutrophil Migration in a Conditional Transgenic Model: Evidence for CXCR2 Desensitization In Vivo

  2001influential reference
• Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury

  2000cited by this paper
• Cytokine regulation of liver injury and repair

  2000cited by this paper
• Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and kupffer cells

  1998cited by this paper
• Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and KC

  1998cited by this paper
• Differential Cross-regulation of the Human Chemokine Receptors CXCR1 and CXCR2

  1998influential reference
• Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation.

  1997influential reference
• Neutrophil receptors for interleukin-8 and related CXC chemokines.

  1997cited by this paper
• Neutrophil receptors for interleukin-8 and related CXC chemokines.

  1997cited by this paper
• Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.

  1996cited by this paper
• The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.

  1996cited by this paper
• The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor*

  1996cited by this paper
• Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein.

  1995cited by this paper
• A comparison of post‐receptor signal transduction events in Jurkat cells transfected with either IL‐8R1 or IL‐8R2 Chemokine mediated activation of p42/p44 MAP‐kinase (ERK‐2)

  1995cited by this paper
• Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.

  1995influential reference
• The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization.

  1994cited by this paper
• Activation of phospholipase D by interleukin-8 in human neutrophils.

  1994cited by this paper
• Both interleukin-8 receptors independently mediate chemotaxis. Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GRO alpha and NAP-2.

  1994cited by this paper
• Hepatic resection with ischemia of the liver exceeding one hour.

  1994cited by this paper
• Both interleukin‐8 receptors independently mediate chemotaxis

  1994cited by this paper
• The interleukin-8 receptor is encoded by a neutrophil-specific cDNA clone, F3R.

  1991cited by this paper
• Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

  1990cited by this paper
• Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity.

  1990cited by this paper
• Methods for distinguishing ingested from adhering particles.

  1986cited by this paper
• [6] Methods for distinguishing ingested from adhering particles

  1986cited by this paper
• Fluorescence energy transfer measurements on cell surfaces: a critical comparison of steady-state fluorimetric and flow cytometric methods.

  1984cited by this paper

• Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes

  2025cites this paper
• Stress hyperglycaemia following trauma – a survival benefit or an outcome detriment?

  2024cites this paper
• Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis

  2024influential citation
• Human CXCR1 knock-in mice infer functional expression of a murine ortholog.

  2023cites this paper
• CXCL6 promotes the progression of NAFLD through regulation of PPARα.

  2023cites this paper
• Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases.

  2022cites this paper
• The immunological function of CXCR2 in the liver during sepsis

  2022cites this paper
• Temporal metabolic and transcriptomic characteristics crossing islets and liver reveal dynamic pathophysiology in diet-induced diabetes

  2021cites this paper
• Neutralization of TNF-α and IL-1β Regulates CXCL8 Production through CXCL8/CXCR1 Axis in Macrophages during Staphylococcus aureus Infection

  2020cites this paper
• Mycophenolate mofetil preconditioning protects mouse liver against ischemia/reperfusion injury in wild type and toll-like receptor 4 knockout and mice.

  2020cites this paper
• CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation

  2020cites this paper
• CXCL2 attenuates osteoblast differentiation by inhibiting the ERK1/2 signaling pathway

  2019cites this paper
• IL‐8 induces transdifferentiation of mature hepatocytes toward the cholangiocyte phenotype

  2019cites this paper
• New Antiretrovirals for HIV and Antivirals for HBV

  2017cites this paper
• Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration.

  2017cites this paper
• Time-course of plasma inflammatory mediators in a rat model of brain death.

  2017cites this paper
• The impact of sterile inflammation in acute liver injury

  2017cites this paper
• Invited Review Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration

  2017cites this paper
• Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil

  2016cites this paper
• Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors

  2016cites this paper
• Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages

  2016cites this paper
• CXCL6 promotes human hepatocyte proliferation through the CXCR1-NFκB pathway and inhibits collagen I secretion by hepatic stellate cells.

  2016cites this paper
• Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes

  2016cites this paper
• Understanding the molecular aspects of oriental obesity pattern differentiation using DNA microarray

  2015cites this paper
• Mindin deficiency protects the liver against ischemia/reperfusion injury.

  2015cites this paper
• CXC Chemokines Function as a Rheostat for Hepatocyte Proliferation and Liver Regeneration

  2015cites this paper
• CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.

  2015cites this paper
• Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes

  2015cites this paper
• CXC chemokine receptor signaling in liver repair and regeneration

  2015cites this paper
• Caffeic acid attenuates rat liver reperfusion injury through sirtuin 3-dependent regulation of mitochondrial respiratory chain.

  2015cites this paper
• The role of adhesion molecule interactions in the engraftment of transplanted hepatocytes into host liver

  2015cites this paper
• Chemokine receptors as therapeutic targets in liver disease

  2015cites this paper
• Branches of NF-κb signaling pathway regulate hepatocyte proliferation in rat liver regeneration.

  2015cites this paper
• Role of CXC Chemokines in Liver Repair and Regeneration

  2015cites this paper
• The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases

  2014cites this paper
• Inhibiting the Toll-Like Receptor 4 Toll/Interleukin-1 Receptor Domain Protects Against Hepatic Warm Ischemia and Reperfusion Injury in Mice*

  2014cites this paper
• Modulation of chemokine function during inflammation

  2014cites this paper
• Blockade of CXCR2 signalling: A potential therapeutic target for preventing neutrophil-mediated inflammatory diseases

  2014cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cites this paper
• The Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease

  2014cites this paper
• Pretreatment with interleukin‐33 reduces warm hepatic ischemia/reperfusion injury in mice

  2013cites this paper
• Roles of hepatocyte and myeloid CXC chemokine receptor‐2 in liver recovery and regeneration after ischemia/reperfusion in mice

  2013cites this paper
• Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets

  2013cites this paper
• Targeting Cancer Stem Cells with Defined Compounds and Drugs

  2013cites this paper
• Regulatory Mechanisms of Injury and Repair after Hepatic Ischemia/Reperfusion

  2012cites this paper
• The Role of Chemokines in Acute Liver Injury

  2012cites this paper
• Ischemia/Reperfusion in Clamped Lobes Facilitates Liver Regeneration of Non-clamped Lobes After Selective Portal Vein Ligation

  2012cites this paper
• CXCR1 deficiency does not alter liver regeneration after partial hepatectomy in mice.

  2011cites this paper
• Therapeutic potential of chemokine receptor antagonists for liver disease

  2011cites this paper
• CXC chemokine signaling in the liver: Impact on repair and regeneration

  2011cites this paper